Search research articles
Contact Us
Filters
Showing results (1-10 of 167) with videos related to
Page
of 17
Sort By:
Current Drug Targets
|
November 14, 2009
Molecular targets in malignant pleural mesothelioma treatment
Giulia Pasello, Adolfo Favaretto
Lancet (London, England)
|
January 24, 2021
Immune checkpoint inhibitors in mesothelioma: a turning point
Giovanni Luca Ceresoli, Giulia Pasello
Current Radiopharmaceuticals
|
December 21, 2019
PET/CT and the Response to Immunotherapy in Lung Cancer
Laura Evangelista, Matteo Sepulcri, Giulia Pasello
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 21, 2022
Pericardial Mesothelioma, a Disease for Brave Hearts
Federica Grosso, Luigi Cerbone, Giulia Pasello
Translational Lung Cancer Research
|
July 23, 2021
Immunotherapy in malignant pleural mesothelioma: a review of literature data
Jessica Menis, Giulia Pasello, Jordi Remon
Discovery Medicine
|
December 31, 2009
Second and third line treatment in advanced non-small cell lung cancer
Adolfo G Favaretto, Giulia Pasello, Cristina Magro
Frontiers in Oncology
|
April 1, 2022
Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
Giulia Pasello, Jordi Remon, Emanuela Felley-Bosco
The Oncologist
|
September 18, 2013
Effects of sulfonylureas on tumor growth: a review of the literature
Giulia Pasello, Loredana Urso, Pierfranco Conte, et al.
Journal of Thoracic Disease
|
June 28, 2019
Editorial on "The AvaALL Randomized Clinical Trial"
Laura Bonanno, Alberto Pavan, Giulia Pasello, et al.
Experimental and Therapeutic Medicine
|
February 19, 2016
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature
Anna Ferrazzi, Irene Russo, Giulia Pasello, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 167) with videos related to
Sort By:
Page
of 17
Current Drug Targets
|
November 14, 2009
Molecular targets in malignant pleural mesothelioma treatment
Giulia Pasello, Adolfo Favaretto
Lancet (London, England)
|
January 24, 2021
Immune checkpoint inhibitors in mesothelioma: a turning point
Giovanni Luca Ceresoli, Giulia Pasello
Current Radiopharmaceuticals
|
December 21, 2019
PET/CT and the Response to Immunotherapy in Lung Cancer
Laura Evangelista, Matteo Sepulcri, Giulia Pasello
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 21, 2022
Pericardial Mesothelioma, a Disease for Brave Hearts
Federica Grosso, Luigi Cerbone, Giulia Pasello
Translational Lung Cancer Research
|
July 23, 2021
Immunotherapy in malignant pleural mesothelioma: a review of literature data
Jessica Menis, Giulia Pasello, Jordi Remon
Discovery Medicine
|
December 31, 2009
Second and third line treatment in advanced non-small cell lung cancer
Adolfo G Favaretto, Giulia Pasello, Cristina Magro
Frontiers in Oncology
|
April 1, 2022
Editorial: Understanding the Interplay Between the Tumor Immune Microenvironment and Genetic Alterations in Thoracic Malignancies
Giulia Pasello, Jordi Remon, Emanuela Felley-Bosco
The Oncologist
|
September 18, 2013
Effects of sulfonylureas on tumor growth: a review of the literature
Giulia Pasello, Loredana Urso, Pierfranco Conte, et al.
Journal of Thoracic Disease
|
June 28, 2019
Editorial on "The AvaALL Randomized Clinical Trial"
Laura Bonanno, Alberto Pavan, Giulia Pasello, et al.
Experimental and Therapeutic Medicine
|
February 19, 2016
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature
Anna Ferrazzi, Irene Russo, Giulia Pasello, et al.
Page
of 17